Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
6 hedge funds and large institutions have $7.64M invested in Forward Pharma A/S American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
15% less capital invested
Capital invested by funds: $9.02M → $7.64M (-$1.38M)
25% less funds holding
Funds holding: 8 → 6 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$74.6K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$7.07K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
-$544K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$120 |
FWP Hedge Fund Activity: Q1 2020 in Review
6 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2020, worth a combined $7.64M — down 15% from $9.02M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FWP and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $74.6K. The largest seller was Newtyn Management, cutting an estimated $544K.
- 6 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2020, down from 8 in Q4 2019.
- Funds reported $7.64M of Forward Pharma A/S American Depositary Shares stock for Q1 2020, down 15% quarter-over-quarter.
- 2 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q1 2020 was Morgan Stanley, an estimated $74.6K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2020 was Newtyn Management, an estimated $544K sold.
Based on aggregated 13F filings for Q1 2020.